Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Cll-Venetoclax'

Cll-Venetoclax published presentations and documents on DocSlides.

Update on chronic lymphocytic leukemia (CLL) treatment
Update on chronic lymphocytic leukemia (CLL) treatment
by joy
Dr Mona Yuklea. Hematology Department, Meir Hospi...
Confirmation Hymns reproduced under licence CLL 27398 and Calamus 0269
Confirmation Hymns reproduced under licence CLL 27398 and Calamus 0269
by carny
Mallaig. Sprinkling Song . Spirit of God, come dw...
CLL Stromal cell protect
CLL Stromal cell protect
by tawny-fly
CLL Stromal cell protect Conventional therapies V...
Clonal Evolution in CLL:
Clonal Evolution in CLL:
by karlyn-bohler
Impact . on t. iming . of . therapy. Nicholas Chi...
Dr.V.Shanthi Associate Professor , Pathology
Dr.V.Shanthi Associate Professor , Pathology
by luna
Sri . Venkateswara. Institute of Medical Sciences...
Hima Darapu, MD Princeton Baptist Medical Center
Hima Darapu, MD Princeton Baptist Medical Center
by felicity
Baptist Health systems Alabama. Baseline Flow Cyto...
groupoflymphoidmalignancieswhichshareclinicalandprognosticfeaturesofin
groupoflymphoidmalignancieswhichshareclinicalandprognosticfeaturesofin
by erica
Table1ClinicalandimagingcharacteristicsofBcellindo...
uidelines
uidelines
by stella
Pan - London Haemato - O ncology Clinical G Lymph...
Reproducible diagnosis of
Reproducible diagnosis of
by davis
Title: Chronic Lymphocytic Leukemia by flow cyto...
Chronic Lymphocytic
Chronic Lymphocytic
by caitlin
A Guide for Being diagnosed with Chronic Lymphocy...
PATIENT EDUCATION
PATIENT EDUCATION
by brooke
Introduction Chronic lymphocytic leukemia (CLL) is...
Presenter : CR 周益聖
Presenter : CR 周益聖
by CottonTails
Supervisor: VS . 曾主任. Cell 152, 714–726, F...
Survival and Clinical Aspects for Patients with Chronic Lymphocytic Leukemia in Kermanshah, Iran
Survival and Clinical Aspects for Patients with Chronic Lymphocytic Leukemia in Kermanshah, Iran
by Tigerwoods
Mehrdad. . Payandeh. Department of Hematology and...
CHARACTERIZATION AND MANAGEMENT OF SYNCHRONOUS DUAL HEMATOLOGICAL MALIGNANCIES
CHARACTERIZATION AND MANAGEMENT OF SYNCHRONOUS DUAL HEMATOLOGICAL MALIGNANCIES
by susan
Rouslan Kotchetkov. ,. MD, PhD. 1. , Erin Ellison...
Using DNA copy number aberrations to
Using DNA copy number aberrations to
by pamela
identify candidate drivers of . carcinogenesis in ...
C hronic lymphocytic
C hronic lymphocytic
by della
leukemia. Magdalena Olszewska-Szopa. Definition. C...
www.society -for- hematopathology.org
www.society -for- hematopathology.org
by yvonne
SH2021-XX . Marrow involvement by clonally-related...
Curriculum Guide 2012 French I
Curriculum Guide 2012 French I
by audrey
Unit Objectives Approx 15 week per unit New Essent...
A Phase 1 Study of the Selective Phosphatidylinositol 3-Kinase-Delta (PI3K
A Phase 1 Study of the Selective Phosphatidylinositol 3-Kinase-Delta (PI3K
by windbey
δ. ) Inhibitor, . Idelalisib. (GS-1101) in Combi...
Pharmacist Focus on BTK Inhibitors Moderator Shilpa Paul, PharmD, BCOP
Pharmacist Focus on BTK Inhibitors Moderator Shilpa Paul, PharmD, BCOP
by ellena-manuel
Pharmacist Focus on BTK Inhibitors Moderator Shil...
Interesting case conference
Interesting case conference
by natalia-silvester
Mary-Margaret Allen, MD. February 24, 2015. 58 . ...
Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
by conchita-marotz
ASH Review 2012. Stephen Spurgeon (spurgeos@ohsu....
Making Sense of Novel Prognostics: NOTCH1, SF3B1
Making Sense of Novel Prognostics: NOTCH1, SF3B1
by olivia-moreira
Jennifer R Brown, MD PhD. Director, CLL Center. D...
Integration of Novel Therapies in WM and CLL : When and How
Integration of Novel Therapies in WM and CLL : When and How
by giovanna-bartolotta
Neil E Kay, M.D.. October 2014. Mayo Team. Deb Bo...
chronic lymphocytic leukemia
chronic lymphocytic leukemia
by test
is the most common type of . leukemia. . . CLL in...
Case 2012-09
Case 2012-09
by tawny-fly
Diagnostic Slide Session. AANP - Annual Meeting. ...
Mechanisms of
Mechanisms of
by giovanna-bartolotta
Ibrutinib. Sensitivity and Resistance in CLL. Y....
Chronic lymphocytic leukemia,
Chronic lymphocytic leukemia,
by natalia-silvester
New agents timing?. Agne Paner, MD. Assistant pro...
Implementing Best Practices in Chronic Lymphocytic Leukemia
Implementing Best Practices in Chronic Lymphocytic Leukemia
by myesha-ticknor
CLL/SLL. Use of Markers in Nonclinical Trial Prac...
Case Study Interpretation
Case Study Interpretation
by lindy-dunigan
Spring 2010. Clinical history. A 62 year old man ...
CCVPN Support for Intent
CCVPN Support for Intent
by audrey
2. Timeline of CCVPN and its relation with Net Sli...
Synthesis and biological evaluation of new
Synthesis and biological evaluation of new
by caroline
N. -substituted 9-nitro-12,14-dioxo-9,10-dihydro-9...
Bill Kobren Director, Logistics & Sustainment Center
Bill Kobren Director, Logistics & Sustainment Center
by danya
Defense Acquisition University. E-mail: bill.kobre...
B‐cell prolymphocytic
B‐cell prolymphocytic
by angelina
. leukaemia. CLL-related conditions. Monoclonal B-...
What is the difference between LGL
What is the difference between LGL
by bethany
leukemia and chronic lymphocytic l eukemia (C...
Dr. Maher jabbar salih
Dr. Maher jabbar salih
by Vikingwarrior
. Medical oncologist . Al-. basrah. . onco. . Cen...
Pooled Analysis of Cardiovascular Events From Clinical Trials Evaluating
Pooled Analysis of Cardiovascular Events From Clinical Trials Evaluating
by LoneWolf
Acalabrutinib. Monotherapy in Patients With Chron...
EHA Stockholm 2018 Deepak Mannari
EHA Stockholm 2018 Deepak Mannari
by riley
Advances in AML. Doses of . Dano. , . Cladrabine. ...
Chronic Leukemia and
Chronic Leukemia and
by ash
Multiple Myeloma . Chronic Leuke...
2022 Spring Oncology Conference
2022 Spring Oncology Conference
by byrne
Evolving Treatment Strategies. for CLL/SLL and MCL...